Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage biopharmaceutical company, for an upfront ...
Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a commercial-stage biopharmaceutical company with a market capitalization of $2.53 billion, has been positioning itself for a new phase of multi-year growth ...
As part of its continued commitment to developing next-generation cancer therapeutics, Ocean Biomedical is initiating ...
Verywell Health on MSN4d
A New 'Missile' Drug Is Approved To Treat the Most Common Breast Cancer TypeThe FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...
Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...
There are various factors that are driving the ... the burden of cancer by promoting generic drug usage have further propelled market growth. On the other hand, the infectious diseases route ...
The HUMANOID Center at UC San Diego is pioneering organoid research aimed at improving the reliability and reproducibility of ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
A $3.2 million grant from the National Institutes of Health is empowering University of Houston researchers to tackle Rhabdomyosarcoma, a malignant soft tissue sarcoma that has a higher incidence in ...
DAR ES SALAAM is a commercial city that attracts many people in search of better opportunities, leading to significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback